Inventor · disambiguated record
Corinne Reymermier
Also filed as: REYMERMIER CORINNE
5 granted patents·13 pending applications·10 citations·filing 2002–2017
70Inventor score
Files withBASF BEAUTY CARE SOLUTIONS F5COLETICA4BASF BEAUTY CARE SOLUTIONS FRANCE S A S3BOUEZ CHARBEL2PERRIER ERIC2
Top patents by PatentIndex Score
18 records- 0187US8906425B2Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibersPERRIER ERIC·Filed 2012·Granted Dec 9, 2014·8 cites·20 claims
- 0273US10675313B2HAS2-stimulating plant extractsPERRIER ERIC·Filed 2006·Granted Jun 9, 2020·2 cites·12 claims
- 0366US2010040710A1Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.BASF BEAUTY CARE SOLUTIONS F·Filed 2009·Application pending·0 cites
- 0457US2004253220A1Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibresCOLETICA·Filed 2004·Application pending·0 cites
- 0555US10905648B2Composition comprising an extract of leaves of the Lansium domesticum plant and methods of use for depigmentation of the skin and/or skin appendagesBASF BEAUTY CARE SOLUTIONS FRANCE SAS·Filed 2017·Granted Feb 2, 2021·0 cites·20 claims
- 0655US10016356B2Sebum secretion inhibitory agentABDUL MALAK NABIL·Filed 2009·Granted Jul 10, 2018·0 cites·12 claims
- 0754US2010047361A1Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFbBASF BEAUTY CARE SOLUTIONS F·Filed 2009·Application pending·0 cites
- 0852US2011244063A1Novel sebum secretion inhibitory agentBASF BEAUTY CARE SOLUTIONS FRANCE S A S·Filed 2009·Application pending·0 cites
- 0951US2010209407A1Mc-1r, mc-2r, and/or mu opioid receptors modulationBASF BEAUTY CARE SOLUTIONS F·Filed 2008·Application pending·0 cites
- 1051US2010272699A1MC-1R, MC-2R, and/or µ OPIOID RECEPTORS STIMULATIONBASF BEAUTY CARE SOLUTIONS F·Filed 2008·Application pending·0 cites
- 1149US2004258676A1Stimulation of the activity of an isoform of lysyl oxidase for combating against some pathologies due to an incomplete, absent or disorganized elastogenesisCOLETICA·Filed 2004·Application pending·0 cites
- 1246US9308161B2Substance for restoring normal co-expression and interaction between the LOX and NRAGE proteinsBOUEZ CHARBEL·Filed 2012·Granted Apr 12, 2016·0 cites·17 claims
- 1346US2011223264A1Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE ProteinsBOUEZ CHARBEL·Filed 2006·Application pending·0 cites
- 1442US2011014175A1Stimulation of the synthesis of the activity of an isoform of lysl oxidase-like loxl for stimulating the formation of elastic fibresBASF BEAUTY CARE SOLUTIONS FRANCE S A S·Filed 2010·Application pending·0 cites
- 1541US2016095815A1Substance for restoring normal co-expression and interaction between the lox and nrage proteinsBASF BEAUTY CARE SOLUTIONS F·Filed 2015·Application pending·0 cites
- 1640US2004091493A1Active ingredients stimulating type 2 and/or type 3 human beta-defensins and cosmetic or pharmaceutical compositions containing such active ingredientsCOLETICA·Filed 2002·Application pending·0 cites
- 1738US2004096815A1Method of identifying an eventual modification of at least one biological parameter making use of living cells which are subjected to a stress and living cells which are not subjected to this same stressCOLETICA·Filed 2003·Application pending·0 cites
- 1832US2016361250A1Active ingredients stimulating type 2 and/or type 3 human beta-defensins and cosmetic or pharmaceutical compositions containing such active ingredientsBASF BEAUTY CARE SOLUTIONS FRANCE S A S·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →